IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 83 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $71,100,000 | +84.0% | 38,641,462 | +111.0% | 0.60% | +80.0% |
| Q4 2017 | $38,646,000 | +68.1% | 18,315,802 | +77.7% | 0.34% | +80.1% |
| Q3 2017 | $22,984,000 | +29.8% | 10,306,757 | +0.1% | 0.19% | +20.0% |
| Q2 2017 | $17,707,000 | -30.3% | 10,294,970 | +0.1% | 0.16% | -25.5% |
| Q1 2017 | $25,408,000 | +64.9% | 10,286,483 | +0.1% | 0.21% | +37.7% |
| Q4 2016 | $15,408,000 | -14.2% | 10,272,314 | +46.5% | 0.15% | -7.4% |
| Q3 2016 | $17,956,000 | +67.6% | 7,014,015 | +0.2% | 0.16% | +45.5% |
| Q2 2016 | $10,711,000 | -22.6% | 7,000,977 | +0.2% | 0.11% | -23.3% |
| Q1 2016 | $13,841,000 | -35.9% | 6,990,189 | +0.1% | 0.15% | -18.4% |
| Q4 2015 | $21,578,000 | -7.7% | 6,983,107 | +0.1% | 0.18% | -17.1% |
| Q3 2015 | $23,370,000 | -9.6% | 6,976,162 | +0.1% | 0.22% | -4.8% |
| Q2 2015 | $25,862,000 | +0.1% | 6,970,902 | +0.1% | 0.23% | +5.6% |
| Q1 2015 | $25,842,000 | +259.9% | 6,965,432 | +327.8% | 0.22% | +194.5% |
| Q4 2014 | $7,181,000 | +93.7% | 1,628,172 | +0.6% | 0.07% | +55.3% |
| Q3 2014 | $3,708,000 | -20.7% | 1,619,258 | +0.4% | 0.05% | -17.5% |
| Q2 2014 | $4,678,000 | -28.9% | 1,613,076 | 0.0% | 0.06% | -32.1% |
| Q1 2014 | $6,581,000 | -55.2% | 1,613,076 | -49.1% | 0.08% | -59.4% |
| Q4 2013 | $14,685,000 | +43.9% | 3,171,765 | -45.9% | 0.21% | +42.8% |
| Q3 2013 | $10,205,000 | +246.2% | 5,865,000 | +30.3% | 0.14% | +150.0% |
| Q2 2013 | $2,948,000 | – | 4,500,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|